142 research outputs found

    Transmit design for MIMO wiretap channel with a malicious jammer

    Full text link
    In this paper, we consider the transmit design for multi-input multi-output (MIMO) wiretap channel including a malicious jammer. We first transform the system model into the traditional three-node wiretap channel by whitening the interference at the legitimate user. Additionally, the eavesdropper channel state information (ECSI) may be fully or statistically known, even unknown to the transmitter. Hence, some strategies are proposed in terms of different levels of ECSI available to the transmitter in our paper. For the case of unknown ECSI, a target rate for the legitimate user is first specified. And then an inverse water-filling algorithm is put forward to find the optimal power allocation for each information symbol, with a stepwise search being used to adjust the spatial dimension allocated to artificial noise (AN) such that the target rate is achievable. As for the case of statistical ECSI, several simulated channels are randomly generated according to the distribution of ECSI. We show that the ergodic secrecy capacity can be approximated as the average secrecy capacity of these simulated channels. Through maximizing this average secrecy capacity, we can obtain a feasible power and spatial dimension allocation scheme by using one dimension search. Finally, numerical results reveal the effectiveness and computational efficiency of our algorithms.Comment: 2015 IEEE 81st Vehicular Technology Conference (VTC Spring

    NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance

    Get PDF
    Lack of proper innate sensing inside tumor microenvironment (TME) limits T cell-targeted immunotherapy. NAD(P)H:quinone oxidoreductase 1 (NQO1) is highly enriched in multiple tumor types and has emerged as a promising target for direct tumor-killing. Here, we demonstrate that NQO1-targeting prodrug β-lapachone triggers tumor-selective innate sensing leading to T cell-dependent tumor control. β-Lapachone is catalyzed and bioactivated by NQO1 to generate ROS in NQO1high tumor cells triggering oxidative stress and release of the damage signals for innate sensing. β-Lapachone-induced high mobility group box 1 (HMGB1) release activates the host TLR4/MyD88/type I interferon pathway and Batf3 dendritic cell-dependent cross-priming to bridge innate and adaptive immune responses against the tumor. Furthermore, targeting NQO1 is very potent to trigger innate sensing for T cell re-activation to overcome checkpoint blockade resistance in well-established tumors. Our study reveals that targeting NQO1 potently triggers innate sensing within TME that synergizes with immunotherapy to overcome adaptive resistance

    Pharmacokinetics, tissue distribution, and antitumor activity of a novel compound, NY-2, in non-small cell lung cancer

    Get PDF
    Introduction: ZLDI-8, which has a relatively strong antitumor activity, is an inhibitor of ADAM-17 and acts on the Notch signaling pathway. To further optimize its structure and improve its activity, a series of derivatives of ZLDI-8 was synthesized. NY-2 was the most effective derivative based on preliminary activity screening in vitro, with no obvious toxicity after administration in vivo.Method: The study aimed to determine the pharmacokinetics, tissue distribution, hepatotoxicity, nephrotoxicity, and antitumor activity of compound NY-2 on non-small cell lung cancer (NSCLC) in vitro and in vivo.Results: The in vivo pharmacokinetics parameters of NY-2 were better than those of ZLDI-8. The tissue distribution analysis showed that tail vein injection of 6 mg/kg of NY-2 in rats resulted in the highest concentration in the lung, so we hypothesized that NY-2 might be effective in the treatment of non-small cell lung cancer. In vitro assays showed that NY-2 significantly inhibited tumor colony formation, invasion, and migration and increased LDH activity and apoptosis in a concentration-dependent manner in non-small cell lung cancer cells. NY-2 also inhibited the formation of lung metastases without significant toxicity to major organs in nude mice.Conclusion: Compared with the parent compound, ZLDI-8, the activity and safety of NY-2 were higher. NY-2 acts on ADAM17 and simultaneously affects the downstream Notch1 and integrinβ1 signaling pathways resulting in antitumor activity. Thus, NY-2 could be a potential antitumor agent, inhibiting the organization and development of non-small cell lung cancer

    Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy

    Get PDF
    Latent autoimmune diabetes in adults (LADA) is a type of diabetes characterized by slow autoimmune damage of pancreatic β cells without insulin treatment in the early clinical stage. There are differences between LADA and classical type 1 diabetes (T1D) and type 2 diabetes (T2D) in genetic background, autoimmune response, rate of islet function decline, clinical metabolic characteristics, and so on. The disease progression and drug response of patients with LADA are closely related to the level of islet autoimmunity, thus exploring the pathogenesis of LADA is of great significance for its prevention and treatment. Previous studies reported that adaptive immunity and innate immunity play a critical role in the etiology of LADA. Recent studies have shown that the intestinal microbiota which impacts host immunity hugely, participates in the pathogenesis of LADA. In addition, the progression of autoimmune pancreatic β cell destruction in LADA is slower than in classical T1D, providing a wider window of opportunities for intervention. Therefore, therapies including antidiabetic drugs with immune-regulation effects and immunomodulators could contribute to promising interventions for LADA. We also shed light on potential interventions targeting the gut microbiota and gut-associated immunity, which may be envisaged to halt or delay the process of autoimmunity in LADA

    Accelerated Transport through Sliding Dynamics of Rodlike Particles in Macromolecular Networks

    Full text link
    Transport of rodlike particles in macromolecular networks is critical for many important biological processes and technological applications. Here, we report that speeding-up dynamics occurs once the rod length L reaches around integral multiple of the network mesh size ax. We find that such a fast diffusion follows the sliding dynamics and demonstrate it to be anomalous yet Brownian. The good agreement between theoretical analysis and simulations corroborates that sliding dynamics is an intermediate regime between hopping and Brownian dynamics, and suggests a mechanistic interpretation based on the rod-length dependent entropic free energy barrier. These theoretical findings are captured by the experimental observations of rods in synthetic networks, and bring new insight into the physics of the transport dynamics in confined media of networks

    Joint communication and control for mmWave/THz beam alignment in V2X networks

    Get PDF
    As promising candidate frequency bands, millimeter wave (mmWave) and terahertz (THz) communications can provide ultra-high transmission rate to enable vehicle-to-everything (V2X) networks for connected autonomous vehicles (CAV). However, beam alignment is extremely challenging in mmWave/THz communications due to its narrow beam-width and fast mobility of CAV. In this paper, we propose a new joint communication and control algorithm for beam alignment, where the mutual positive effect of communications and motion control of CAV on each other is discussed. Specifically, we first provide a framework to show the interaction between motion control of CAV and beam alignment of transmission from base station (BS) to CAV. Then, we analyze the effect of CAV control on beam alignment in communications, where a theorem is obtained to show the closed-form expression of their relationship. Finally, we discuss the CAV control design affected by beam alignment. Simulation results show remarkable performance of the proposed method

    Construction of a one-step multiplex real-time PCR assay for the detection of serogroups A, B, and E of Pasteurella multocida associated with bovine pasteurellosis

    Get PDF
    Bovine pasteurellosis, caused by serogroups A, B, and E of Pasteurella multocida (Pm), is mainly manifested as bovine respiratory disease (BRD) and hemorrhagic septicemia (HS). The disease has caused a great economic loss for the cattle industry globally. Therefore, identifying the Pm serogroups is critical for optimal diagnosis and subsequent clinical treatment and even epidemiological studies. In this study, a one-step multiplex real-time PCR assay was established. Three pairs of specific primers were prepared to detect the highly conserved genomic regions of serogroups A (HyaD), B (bcbD), and E (ecbJ) of Pm, respectively. The results depicted that the method had no cross-reaction with other bovine pathogens (Mannheimia hemolytica, Escherichia coli, Listeria monocytogenes, Staphylococcus aureus, Salmonella Dublin, Mycobacterium paratuberculosis, infectious bovine rhinotracheitis virus, and Mycoplasma bovis). The linear range (107 to 102 copies/μL) showed the R2 values for serogroups A, B, and E of Pm as 0.9975, 0.9964, and 0.996, respectively. The multiplex real-time PCR efficiency was 90.30%, 90.72%, and 90.57% for CartA, CartB, and CartE, respectively. The sensitivity result showed that the serogroups A, B, and E of Pm could be detected to be as low as 10 copies/μL. The repeatability result clarified that an intra-assay and an inter-assay coefficient of variation of serogroups A, B, and E of Pm was < 2%. For the clinical samples, the detection rate was higher than the OIE-recommended ordinary PCR. Overall, the established one-step multiplex real-time PCR assay may be a valuable tool for the rapid and early detection of the serogroups A, B, and E of Pm with high specificity and sensitivity

    Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.

    Get PDF
    Isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) has a dismal prognosis. A better understanding of tumor evolution holds the key to developing more effective treatment. Here we study GBM\u27s natural evolutionary trajectory by using rare multifocal samples. We sequenced 61,062 single cells from eight multifocal IDH wild-type primary GBMs and defined a natural evolution signature (NES) of the tumor. We show that the NES significantly associates with the activation of transcription factors that regulate brain development, including MYBL2 and FOSL2. Hypoxia is involved in inducing NES transition potentially via activation of the HIF1A-FOSL2 axis. High-NES tumor cells could recruit and polarize bone marrow-derived macrophages through activation of the FOSL2-ANXA1-FPR1/3 axis. These polarized macrophages can efficiently suppress T-cell activity and accelerate NES transition in tumor cells. Moreover, the polarized macrophages could upregulate CCL2 to induce tumor cell migration. SIGNIFICANCE: GBM progression could be induced by hypoxia via the HIF1A-FOSL2 axis. Tumor-derived ANXA1 is associated with recruitment and polarization of bone marrow-derived macrophages to suppress the immunoenvironment. The polarized macrophages promote tumor cell NES transition and migration. This article is highlighted in the In This Issue feature, p. 2711
    • …
    corecore